BrukerSTU:BKD +5.61%83 OCF Yield % is 1.67 as of Jun. 25, 2026, which is 46% below its 10-year median of 3.08. GuruFocus rates STU:BKD with a GF Score™ of 83/100 and a GF Value™ of €53.95 (Fairly Valued). The stock has 10 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Bruker ranks worse than 50.47% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Bruker's OCF Yield % or its related term are showing as below:
STU:BKD'
s OCF Yield % Range Over the Past 10 Years
Min: 1.27 Med: 3.08 Max: 5.84
Current: 1.67
During the past 13 years, the highest OCF Yield % of Bruker was 5.84%. The lowest was 1.27%. And the median was 3.08%.
STU:BKD's OCF Yield % is ranked worse than 50.47% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.76
vs STU:BKD: 1.67
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bruker OCF Yield % Related Terms
Bruker OCF Yield % Historical Data
* Premium members only.
The historical data trend for Bruker's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:BKD vs MASI, BIO, PODD: OCF Yield % Comparison
For the Medical Devices subindustry, Bruker's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bruker OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bruker's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Bruker's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bruker (STU:BKD) has a OCF Yield % of 1.67 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bruker and its competitors. This is 46% below median its historical median of 3.08. Over the past decade, Bruker's OCF Yield % has ranged from 1.27 to 5.84. According to the industry distribution chart, Bruker ranks #430 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Bruker's OCF Yield % too high?
Bruker's current OCF Yield % of 1.67 is 46% below median its 10-year median of 3.08. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 5.84. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Bruker's value of 1.67 is 5.1% below this industry median. Based on the distribution chart, Bruker ranks #430 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bruker has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's OCF Yield % compare to MASI and BIO?
According to the Medical Devices & Instruments industry distribution chart, Bruker ranks #430 out of 852 companies for OCF Yield %. This places Bruker in the lower half of its industry. The industry median OCF Yield % is 1.76. Bruker's value of 1.67 is 5.1% below this benchmark. Historically, Bruker's own OCF Yield % has ranged from 1.27 to 5.84 over the past decade. While the company's 10-year median is 3.08 vs. the industry median of 1.76, Bruker has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bruker's current OCF Yield % of 1.67 is 5.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bruker and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bruker's current OCF Yield % is 1.67, which is 46% below median its own 10-year median of 3.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (STU:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €53.95, compared to a current price of €51.09 — trading 5.3% below its estimated fair value. The current OCF Yield % is 1.67, which is 46% below median its 10-year median of 3.08 and 5.1% below the Medical Devices & Instruments industry median of 1.76. Bruker's overall GF Score™ is 83/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bruker (STU:BKD), the current OCF Yield % is 1.67 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bruker (STU:BKD) Overvalued in 2026?
Based on GuruFocus' analysis, Bruker stock appears to be undervalued.
The current stock price of €51.09 is trading 5.3% below its estimated GF Value™ of €53.95.
GuruFocus considers Bruker to be Fairly Valued.
Key valuation signals for STU:BKD:
OCF Yield %: 1.67 (46% below median its 10-year median of 3.08)
GF Value™: €53.95 vs. price of €51.09 (5.3% below fair value)
Industry Position: 5.1% below the Medical Devices & Instruments median (#430 of 852)
No single metric tells the full story. See the STU:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
83GF Score
Get the complete analysis for STU:BKD
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BKD has been successfully added to your 
